Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MRAS |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → MRAS |
| (<<) CASP9 → MRAS |
| (<<) CCND2 → MRAS |
| (<<) EEF1E1 → MRAS |
| (<<) ENC1 → MRAS |
| (<<) EPHA4 → MRAS |
| (<<) GLTPD1 → MRAS |
| (<<) LIMK1 → MRAS |
| (<<) MAP3K9 → MRAS |
| (<<) MMP25 → MRAS |
| (<<) NOTCH1 → MRAS |
| (<<) PIK3CB → MRAS |
| (<<) PTGER1 → MRAS |
| (<<) PTRF → MRAS |
| (<<) RAD51L3 → MRAS |
| (<<) SGCA → MRAS |
| (<<) SMURF1 → MRAS |
| (<<) SPPL2B → MRAS |
| (<<) STK4 → MRAS |
| (<<) TGFA → MRAS |
| (<<) TYK2 → MRAS |
| Downstream (Children) |
|---|
| MRAS → CREB3L1 (>>) |
| MRAS → CSF2 (>>) |
| MRAS → CTNNB1 (>>) |
| MRAS → GRK5 (>>) |
| MRAS → HDAC5 (>>) |
| MRAS → HK2 (>>) |
| MRAS → HOXA3 (>>) |
| MRAS → KLK3 (>>) |
| MRAS → KLK5 (>>) |
| MRAS → LIF (>>) |
| MRAS → MYL3 (>>) |
| MRAS → PIK3CG (>>) |
| MRAS → SLC26A1 (>>) |
| MRAS → TPSG1 (>>) |
| MRAS → ZFP36L1 (>>) |
